Skip to content

A randomised trial to understand the benefits of a new intervention designed to reduce muscle overactivity in people with knee osteoarthritis

BEhaviour change for People with clinically diagnosed Knee Osteoarthritis: A pragmatic trial (BEPKO-3)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN17829217
Enrollment
252
Registered
2026-02-09
Start date
2026-02-09
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis Musculoskeletal Diseases

Interventions

Participants will then be randomly assigned to one of two groups. This assignment is done using a process called randomisation, which is similar to flipping a coin. It ensures that each participant ha

Sponsors

University of Salford
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 120 Years

Inclusion criteria

Inclusion criteria: 1. Aged 45 years or older. (KOA is most common in people over 45 and used in NICE criteria for knee osteoarthritis) 2. Activity-related joint pain (These are typical clinical signs of knee osteoarthritis and help confirm the diagnosis without needing an X-ray) 3. Morning stiffness lasting less than 30 minutes. (These are typical clinical signs of knee osteoarthritis and help confirm the diagnosis without needing an X-ray) 4. Score 4 or more (out of 20) on the WOMAC pain scale. (This ensures participants have a minimum level of pain, making it possible to detect meaningful improvements from the intervention) 5. Knee pain lasting more than 6 months. (This ensures participants have a long-term condition and are not experiencing temporary or acute symptoms) 6. Have tried therapeutic exercise and are dissatisfied with the outcome. (CMT is designed as a second-line treatment for people who have not responded well to exercise therapy, which is the first recommended treatment for knee OA) 7. Able to stand for 5 minutes and walk independently with no more than one walking stick or elbow crutch. (The intervention involves physical tasks such as standing, walking, and stair climbing. Participants need a basic level of mobility to safely take part) 8. Able to attend for seven hour-long intervention sessions with a physiotherapist (to receive the intervention)

Exclusion criteria

Exclusion criteria: 1. Body Mass Index (BMI) over 33 kg/m². (Excess body fat can interfere with the equipment used to measure muscle activity (electromyography), which is essential for the treatment) 2. Systemic inflammatory arthritis (e.g. rheumatoid arthritis). (This is a different type of joint condition that requires other forms of treatment and may respond differently to the intervention) 3. Diagnosis of a widespread pain condition (e.g. fibromyalgia). (These conditions involve pain throughout the body and may not benefit from a treatment focused specifically on the knee) 4. Neurological disorders. (These conditions may affect movement and safety during the physical parts of the treatment) 5. Diagnosis of dementia and score > 17 on the Telephone-Mini mental state examination (T-MMSE). (Participants need be able to understand intervention materials to benefit. If dementia is diagnosed, we will assess severity using the T-MMSE and include those with mild impairment) 6. Unable to speak English well enough to understand the treatment and complete study tasks (The treatment involves detailed explanations and guided exercises. Participants need to understand instructions clearly to benefit and stay safe. We have no budget to translate intervention materials or pay translators)

Countries

England, United Kingdom

Contacts

Public ContactStephen Preece
s.preece@salford.ac.uk-

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Jun 29, 2026